1. Home
  2. ZKH vs PACB Comparison

ZKH vs PACB Comparison

Compare ZKH & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZKH Group Limited

ZKH

ZKH Group Limited

N/A

Current Price

$2.92

Market Cap

465.1M

Sector

N/A

ML Signal

N/A

Logo Pacific Biosciences of California Inc.

PACB

Pacific Biosciences of California Inc.

N/A

Current Price

$1.37

Market Cap

521.8M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ZKH
PACB
Founded
1998
2000
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
465.1M
521.8M
IPO Year
2022
2010

Fundamental Metrics

Financial Performance
Metric
ZKH
PACB
Price
$2.92
$1.37
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$1.67
AVG Volume (30 Days)
111.6K
7.0M
Earning Date
05-19-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$93,468,000.00
Revenue This Year
$9.02
$11.32
Revenue Next Year
$10.41
$12.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.04
52 Week Low
$1.92
$1.07
52 Week High
$3.90
$2.73

Technical Indicators

Market Signals
Indicator
ZKH
PACB
Relative Strength Index (RSI) 53.65 52.70
Support Level $2.88 $1.27
Resistance Level $2.98 $1.47
Average True Range (ATR) 0.10 0.10
MACD -0.01 0.02
Stochastic Oscillator 76.81 66.25

Price Performance

Historical Comparison
ZKH
PACB

About ZKH ZKH Group Limited

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. Majority of the revenues are derived from the PRC.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.

Share on Social Networks: